Atea Pharmaceuticals (AVIR) Accumulated Depreciation & Amortization (2020 - 2021)
Historic Accumulated Depreciation & Amortization for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q4 2021 value amounting to $161000.0.
- Atea Pharmaceuticals' Accumulated Depreciation & Amortization rose 2196.97% to $161000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $161000.0, marking a year-over-year increase of 2196.97%. This contributed to the annual value of $161000.0 for FY2021, which is 2196.97% up from last year.
- According to the latest figures from Q4 2021, Atea Pharmaceuticals' Accumulated Depreciation & Amortization is $161000.0, which was up 2196.97% from $132000.0 recorded in Q4 2020.
- In the past 5 years, Atea Pharmaceuticals' Accumulated Depreciation & Amortization ranged from a high of $161000.0 in Q4 2021 and a low of $126000.0 during Q3 2020